Startups
Edit
https://www.drugpatentwatch.com/
DrugPatentWatch Pharmaceutical Drug Patent Intelligence
TrustedLast activity: 01.10.2026
Active
Global biopharmaceutical drug patent and generic entry business intelligence.
DrugPatentWatch Supports Critical Business Decisions:
>Payers: Formulary and pharmacy & therapeutics (P&T)
Anticipate future budget requirements and proactively identify generic sources
> Branded pharmaceutical manufacturers
Assess past successes of patent challengers and elucidate research paths of competitors
> Generic manufacturers
Inform portfolio management decisions on future drug development
> Buyers, wholesalers, and distributors
Predict branded drug patent expiration, identify generic suppliers, and prevent overstock of branded drugs
> API manufacturers
Obtain formulation and manufacturing information; identify final formulators, repackagers, and relabellers
DrugPatentWatch Supports Critical Business Decisions:
>Payers: Formulary and pharmacy & therapeutics (P&T)
Anticipate future budget requirements and proactively identify generic sources
> Branded pharmaceutical manufacturers
Assess past successes of patent challengers and elucidate research paths of competitors
> Generic manufacturers
Inform portfolio management decisions on future drug development
> Buyers, wholesalers, and distributors
Predict branded drug patent expiration, identify generic suppliers, and prevent overstock of branded drugs
> API manufacturers
Obtain formulation and manufacturing information; identify final formulators, repackagers, and relabellers
Overview
Location
United States, District of Columbia, Washington
Employees
1-10
Founded date
2003
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 4, 2026 | Pfizer Q2 2026 Earnings Beat Estimates; Non-COVID Revenue Surges 18% Operationally | By Jerry Owens Published: Aug 04 2026, 10:07 AM EDT Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| Dec 18, 2018 | Two dozen drugs could go generic this year and next, but the biggest change could happen in Congress | Patents on 24 drugs will expire between the end of 2018 and the end of 2019, leaving them open for generic competition, according to data compiled by a company that aggregates pharmaceutical patent information. But while the list, published... |
| Jan 3, 2017 | Drug patents expiring in 2017? It’s all smoke and mirrors | “I see a lot of articles talking about, ‘this patent for this biologic expires in 2020,'” said Janet Xiao, co-chair of the Global Life Sciences Group at Morrison Foerster. “That may not be the complete story.” Big Pharma has become increasi... |
| Sep 21, 2015 | Company Acquires Rights To Drug Used By AIDS/Cancer Patients; Immediately Raises Per Pill Price From Under $14 To $750 | When pharmaceutical companies defend outrageously-priced medicines, they often claim these massive profit margins are there to help them recoup the money dumped into research and development. But that has nothing to do with the high prices.... |
| Drug patents expiring in 2017? It’s all smoke and mirrors | Once upon a time, reporters could definitively track down what drug patents would expire in a given year. Like lemmings, the medicines ran straight off the proverbial patent cliff. Generic manufacturers swooped in en masse and the inventor ... | |
| Two dozen drugs could go generic this year and next, but the biggest change could happen in Congress | Patents on 24 drugs will expire between the end of 2018 and the end of 2019, leaving them open for generic competition, according to data compiled by a company that aggregates pharmaceutical patent information. But while the list, published... |
Reviews 0
FAQ about DrugPatentWatch Pharmaceutical Drug Patent Intelligence
When was DrugPatentWatch Pharmaceutical Drug Patent Intelligence founded?
DrugPatentWatch Pharmaceutical Drug Patent Intelligence was founded in 2003.
What has the press written about DrugPatentWatch Pharmaceutical Drug Patent Intelligence?
Parsers VC has collected 7 articles mentioning DrugPatentWatch Pharmaceutical Drug Patent Intelligence, among them “Pfizer Q2 2026 Earnings Beat Estimates; Non-COVID Revenue Surges 18% Operationally” (Aug 4, 2026) and “Two dozen drugs could go generic this year and next, but the biggest change could happen in Congress” (Dec 18, 2018).
Is DrugPatentWatch Pharmaceutical Drug Patent Intelligence still active?
Yes, DrugPatentWatch Pharmaceutical Drug Patent Intelligence is active; its latest activity on Parsers VC dates from Oct 1, 2026.